Where will life science be in #TheNext10 years?  What cures, new technologies, treatments, research breakthroughs, and innovations will we see by 2025?  Answering those questions will be our focus at the CED Life Science Conference 2015, March 3-4 in Raleigh, NC.  This conference, presented in partnership with the North Carolina Biotechnology Center and NCBIO, regularly attracts over 1,000 participants each year, connecting entrepreneurs, corporate leaders, university researchers, venture capital, angel, and strategic investors from around the nation.  This year we’ll be featuring presentations from thirteen of the most disruptive and exciting Biotech/Pharma, Med Device, Diagnostics, and Digital Health companies in the region.  The conference will also offer #TheNext10 Innovation Room, providing exposure to over 50 of the Southeast’s top emerging life science companies. And we’ve expanded opportunities to network and partner with colleagues and the companies that catch your interest during the event, and have upgraded the technology that makes partnering seamless.

Some of our featured speakers at CED Life Science Conference 2015:

  • John Lechleiter, CEO, President, & Chairman, Eli Lilly & Co
  • Herb Boyer, Co-Founder of Genentech
  • Dennis Gillings, Founder and Executive Chairman, Quintiles
  • Vikram Bajaj, Principal Scientist, Google X Life Sciences
  • Fred Cohen, Partner and Managing Director, TPG Ventures
  • Steve Bloch, General Partner, Canaan Partners
  • Leslie Bottorff, Managing Director, Healthcare, GE Ventures
  • Bob Beall, CEO, Cystic Fibrosis Foundation
  • Iain Dukes, SVP, Business Development, Merck
  • Rolf Hoffmann, SVP, U.S. Commercial Operations, Amgen
  • Brad Perkins, CMO, Human Longevity, Inc
  • Richard Moscicki, Deputy Director, CDER, FDA